TopoGEN is a research diagnostic company that provides innovative products for researchers working with topoisomerases and engaged in mechanism based drug discovery. Kits are available to identify topoisomerase active drugs for use in cancer chemotherapy and antibacterial applications. The company also provides kits for assaying both prokaryotic and eukaryotic topoisomerases (type I, II, IV, gyrase), both in vitro and in vivo. We also offer a complete line of DNA substrates and DNA cleavage targets, topo inhibitors, antibodies, and kit replenishment reagents. The company was founded by researchers working

Website :